The Therapeutic Potential of Human Umbilical Cord Blood Transplantation for Neonatal Hypoxic-Ischemic Brain Injury and Ischemic Stroke a,b* b,c a a b b b b a b a b c
430 Wang et al. Acta Med. Okayama Vol. 66, No. 6 Neonatal hypoxic-ischemic brain injury Ischemic stroke Transplantation of HUCB cells HUCB cells contain HSCs, MSCs, USSCs, stromal precursor cells, endothelial stem cells Therapeutic mechanisms for functional recovery Neuroprotective effects Anti-inflammatory effects Angiogenesis Fig. 1 The transplantation of human umbilical cord blood (HUCB) showed functional recovery in animal models of neonatal hypoxicischemic brain injury and ischemic stroke. The possible mechanisms of transplant therapy include neuroprotective effects, angiogenesis and anti-inflammatory effects. HUCB, human umbilical cord blood; HSCs, hematopoietic stem cells; MSCs, mesenchymal stem cells; USSCs, unrestricted somatic stem cells. and CD45. Endothelial stem cells [8], stromal precursor cells [9], and still-not-fully-characterized populations of stem cells also exist in HUCB. Cells from the mononuclear fraction of HUCB are able to differentiate into multiple lineages under appropriate culture conditions [10]. Unrestricted somatic stem cells (USSCs) are also promising candidates as multipotent stem cells, which were isolated as a CD45negative population from HUCB [11]. USSCs can be differentiated into osteoblasts, chondroblasts, adipocytes, and neural cells. Moreover, the differentiation of USSCs along mesodermal and endodermal pathways has been demonstrated in nude rat femurs. The gene encodes one of the transcription factors that is important in maintaining the multipotency of HUCB stem cells as well as embryonic stem cells. Inhibition of expression in HUCB stem cells inhibits cell proliferation and reduces multipotency [12]. Although these pluripotent stem cell populations are very rare, they may be helpful for the effective treatment of irreversible functional deficits. HUCB Transplantation for Neonatal Hypoxic-Ischemic Brain Injury Cerebral palsy is one of the severe neurodevelopmental sequelae of perinatal hypoxic-ischemic encephalopathy (HIE) [13]. There is currently no effective therapy for the functional regeneration of nerve tissue that is damaged during the perinatal period. The therapeutic potential of HUCB transplantation in animal models of HIE has been evaluated in several laboratories. The neonatal hypoxic-ischemic (HI) brain injury model has proved to be useful as an animal model of perinatal HIE [14, 15]. In this model, 7-day-old pups undergo unilateral common carotid artery ligation followed by systemic hypoxia, leading to unilateral brain damage in the hemisphere ipsilateral to the ligation. In rat models of neonatal HI,
1 2 3 4 5 1996 335 157 166 1997 337 373 381 2007 7 1311 1322 2010 5 17 22 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 1989 86 3828 3832 2004 22 625 634 2012 36 595 600 2000 105 1527 1536 2012 21 1429 1440 2001 7 581 588 2004 200 123 135 4 2009 384 120 125 2011 2011 13 1960 36 1 17 3 1981 9 131 141 2006 59 244 249 2010 19 351 358 2010 14 914 921 2011 6 20194
21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 2009 65 631 635 2001 32 2682 2688 2004 35 2390 2395 2003 73 296 307 2006 199 191 200 2004 35 2385 2389 2011 2 38 2002 11 3 261 264 2007 35 1119 1131 2005 380 322 325 2006 199 201 208 2000 20 5775 5781 2011 32 433 441 2012 287 4177 4187 2009 3 216 223 34 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 2004 114 330 338 34 2004 109 2972 2975 34 2001 97 3075 3085 1 2007 27 339 353 2009 87 3554 3567 2012 348 429 438 1 2 1 2007 27 1684 1691 2009 7 97 2006 26 654 665 10 4 2011 25 820 829 2012 2012 71 444 457 2011 585 3798 3805 2012 40 2438 2448 ʻ ʼ ʻ ʼ 2007 30 596 602 2006 15 213 223